GlassScriptPhysician profile
Tani Sanghvi
NPI 1124173752
$1,037.01
in general payments reported to CMS, 2019-2025
13 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $229 · 2020: $92.95 · 2021: $291 · 2022: $214 · 2023: $42.08 · 2024: $13.35 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $112 · Food and Beverage: $97.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $112.35 |
| Food and Beverage | $97.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $336.18 | 2020-2022 | |
| Therapeuticsmd, INC. | $155.19 | 2019-2022 | |
| Astellas Pharma US INC | $154.44 | 2025 | Veozah |
| Avion Pharmaceuticals | $103.33 | 2021-2023 | Balcoltra |
| Amag Pharmaceuticals, INC. | $59.08 | 2019 | |
| Vertical Pharmaceuticals, LLC | $42.40 | 2019 | |
| Mayne Pharma Commercial LLC | $39.59 | 2021 | |
| Scynexis, INC. | $34.56 | 2022 | |
| Millicent US INC | $28.15 | 2019-2024 | |
| Evofem Biosciences, INC. | $23.02 | 2021 | |
| Exeltis, USA INC. | $22.82 | 2019 | |
| Allergan, INC. | $20.13 | 2019 | |
| Coopersurgical, INC. | $18.12 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tani Sanghvi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.